On April 24, 2024

Vermont to study health benefits, program to permit psychedelic therapy

Last month, the Senate passed S.114, which will establish a psychedelic therapy advisory working group. This group will be tasked with continuing to examine the use of psychedelics to improve physical and mental health. They will also make recommendations regarding the establishment of a Vermont state program to permit health care providers to legally access psychedelics under state law, according to S.114.

“Over the years, many institutions have conducted studies regarding the therapeutic benefits of psilocybin, a naturally occurring psychedelic compound found in some species of fungi,” wrote Lieutenant Governor David Zuckerman in his newsletter earlier this month. “In one Johns Hopkins study published in 2022, researchers demonstrated substantial antidepressant effects of psilocybin with no reported adverse effects from patients. In another study published in the Journal of American Medical Association Psychiatry, psilocybin combined with psychotherapy resulted in an 83% reduction in heavy drinking among patients with alcohol use disorder. It is important that we begin the conversation of changing our policies on the use of psychedelic therapies to help people with PTSD, substance abuse disorders and more.”

It is estimated that about one in five U.S. adults are living with a mental illness. Vermont (and the nation as a whole) has also seen a steep rise in substance use disorders in the past several years.

“The research on psilocybin has shown incredibly promising results in treating these and other conditions. By creating avenues for psychedelic therapy to be used in Vermont, we can help thousands of struggling vulnerable individuals,” Zuckerman wrote.

Per S.114, the working group shall be composed of the following members: (1) a representative of the Larner College of Medicine at the University of Vermont, appointed by the dean; (2) a representative of the Brattleboro Retreat, appointed by the president and chief executive officer; (3) a member of the Vermont Psychological Association, appointed by the president; (4) a member of the Vermont Psychiatric Association, appointed by the president; (5) the executive director of the Vermont Board of Medical Practice or designee; (6) the director of the Vermont Office of Professional Regulation or designee; (7) the Vermont Commissioner of Health or designee; and (8) a co-founder of the Psychedelic Society of Vermont.


“The Vermont Psychological Association shall call the first meeting of the Working Group to occur on or before July 15, 2024,” according to the bill. The Working Group shall select a chair from among its members at the first meeting.

“On or before November 15, 2024, the Working Group shall submit a written report to the House and Senate Committees on Judiciary, the House Committee on Health Care, the House Committee on Human Services, and the Senate Committee on Health and Welfare with its findings and any recommendations for legislative action” the bill specifies.

Do you want to submit feedback to the editor?

Send Us An Email!

Related Posts

Gov. Scott vetoes bill that would’ve restricted bee-killing pesticide

May 22, 2024
Staff report On Monday, May 20, World Bee Day, Gov. Phil Scott vetoed legislation meant to protect bees and other pollinators from a widely-used neuorotoxic pesticide. The bill (H.706) would  eliminate most uses of neonicotinoid pesticides (neonics) in Vermont, which have been associated with alarming losses of managed and wild bee populations. Neonic insecticides are used on…

Health premium increases of 16%-19% projected for 2025

May 22, 2024
Vermonters are again facing steep upward premium growth for 2025 due to the cumulative impact of hospital costs, drug prices and state health care policy choices. Blue Cross and Blue Shield of Vermont projects that these trends will continue and will require rate increases of 16.3% for individual health plans and 19.1% for the small group…

Sanders: weight loss drugs could bankrupt U.S. health care

May 22, 2024
As part of his investigation into the outrageously high price of Ozempic and Wegovy in the U.S., U.S. Sen. Bernie Sanders, chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, released a stunning new report May 15 exposing the potential of weight loss drugs to bankrupt American health care. In the report, HELP…

The future of fertilizer? Pee, says this Brattleboro institute

May 22, 2024
By Kate Kampner, Community News Service Editor’s note: The Community News Service is a program in which University of Vermont students work with professional editors to provide content for local news outlets at no cost. When Peter Stickney walks along his cow paddocks in the morning, he notes the scattered patches of greener grass across the…